vs
Side-by-side financial comparison of Spero Therapeutics, Inc. (SPRO) and Tectonic Financial, Inc. (TECTP). Click either name above to swap in a different company.
Tectonic Financial, Inc. is the larger business by last-quarter revenue ($23.0M vs $12.6M, roughly 1.8× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 23.8%, a 226.8% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 17.9%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 270.5%).
Tectonic Financial, Inc.TECTPEarnings & Financial Report
Tectonic Financial, Inc. is a US-based diversified financial services provider. It offers core services including wealth management, investment banking, capital markets advisory, and tailored financial solutions. Its key client segments cover high-net-worth individuals, institutional investors, and small to mid-sized enterprises across North America.
SPRO vs TECTP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.6M | $23.0M |
| Net Profit | $31.5M | $5.5M |
| Gross Margin | — | — |
| Operating Margin | — | 30.6% |
| Net Margin | 250.7% | 23.8% |
| Revenue YoY | 24080.8% | 17.9% |
| Net Profit YoY | 250.9% | 15.9% |
| EPS (diluted) | $0.56 | $0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.6M | — | ||
| Q3 25 | $0 | $23.0M | ||
| Q2 25 | $0 | $21.6M | ||
| Q1 25 | $12.0K | $21.8M | ||
| Q4 24 | $52.0K | $21.4M | ||
| Q3 24 | $65.0K | $19.5M | ||
| Q2 24 | $114.0K | $18.6M | ||
| Q1 24 | $140.0K | $17.6M |
| Q4 25 | $31.5M | — | ||
| Q3 25 | $-7.4M | $5.5M | ||
| Q2 25 | $-1.7M | $4.3M | ||
| Q1 25 | $-13.9M | $4.5M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $-17.1M | $4.7M | ||
| Q2 24 | $-17.9M | $3.1M | ||
| Q1 24 | $-12.7M | $3.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | 30.6% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | -122758.3% | 26.0% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | -28604.6% | 29.1% | ||
| Q2 24 | -16720.2% | 21.5% | ||
| Q1 24 | -9987.1% | 22.2% |
| Q4 25 | 250.7% | — | ||
| Q3 25 | — | 23.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | -115550.0% | 20.4% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | -26380.0% | 24.2% | ||
| Q2 24 | -15668.4% | 16.9% | ||
| Q1 24 | -9049.3% | 17.4% |
| Q4 25 | $0.56 | — | ||
| Q3 25 | $-0.13 | $0.73 | ||
| Q2 25 | $-0.03 | $0.55 | ||
| Q1 25 | $-0.25 | $0.57 | ||
| Q4 24 | — | $0.35 | ||
| Q3 24 | $-0.32 | $0.58 | ||
| Q2 24 | $-0.33 | $0.38 | ||
| Q1 24 | $-0.24 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $59.0M | $119.2M |
| Total Assets | $68.9M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.3M | — | ||
| Q3 25 | $48.6M | — | ||
| Q2 25 | $31.2M | — | ||
| Q1 25 | $48.9M | — | ||
| Q4 24 | $52.9M | — | ||
| Q3 24 | $76.3M | — | ||
| Q2 24 | $63.5M | — | ||
| Q1 24 | $82.3M | — |
| Q4 25 | $59.0M | — | ||
| Q3 25 | $26.5M | $119.2M | ||
| Q2 25 | $32.8M | $114.6M | ||
| Q1 25 | $33.8M | $111.3M | ||
| Q4 24 | $46.1M | $113.4M | ||
| Q3 24 | $65.5M | $112.8M | ||
| Q2 24 | $80.5M | $110.4M | ||
| Q1 24 | $96.2M | $108.5M |
| Q4 25 | $68.9M | — | ||
| Q3 25 | $54.2M | $1.1B | ||
| Q2 25 | $62.1M | $997.0M | ||
| Q1 25 | $77.7M | $910.5M | ||
| Q4 24 | $110.5M | $863.4M | ||
| Q3 24 | $135.2M | $847.5M | ||
| Q2 24 | $149.9M | $777.1M | ||
| Q1 24 | $167.7M | $777.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.4M | $-17.3M |
| Free Cash FlowOCF − Capex | — | $-17.3M |
| FCF MarginFCF / Revenue | — | -74.9% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -0.26× | -3.14× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.4M | — | ||
| Q3 25 | $17.4M | $-17.3M | ||
| Q2 25 | $-17.7M | $-32.5M | ||
| Q1 25 | $-4.0M | $-35.6M | ||
| Q4 24 | $-23.4M | $-86.6M | ||
| Q3 24 | $12.8M | $-22.5M | ||
| Q2 24 | $-18.7M | $-30.7M | ||
| Q1 24 | $5.9M | $-3.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-17.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-35.6M | ||
| Q4 24 | — | $-86.8M | ||
| Q3 24 | — | $-22.5M | ||
| Q2 24 | — | $-30.7M | ||
| Q1 24 | — | $-3.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -74.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -163.2% | ||
| Q4 24 | — | -406.5% | ||
| Q3 24 | — | -115.0% | ||
| Q2 24 | — | -165.5% | ||
| Q1 24 | — | -18.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | -0.26× | — | ||
| Q3 25 | — | -3.14× | ||
| Q2 25 | — | -7.61× | ||
| Q1 25 | — | -8.00× | ||
| Q4 24 | — | -28.99× | ||
| Q3 24 | — | -4.74× | ||
| Q2 24 | — | -9.76× | ||
| Q1 24 | — | -1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
